rs113206037
Variant names: 
Your query was ambiguous. Multiple possible variants found: 
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_006891.4(CRYGD):c.9+20C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0145 in 1,582,836 control chromosomes in the GnomAD database, including 204 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
 Genomes: 𝑓 0.011   (  9   hom.,  cov: 33) 
 Exomes 𝑓:  0.015   (  195   hom.  ) 
Consequence
 CRYGD
NM_006891.4 intron
NM_006891.4 intron
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  -1.69  
Publications
1 publications found 
Genes affected
 CRYGD  (HGNC:2411):  (crystallin gamma D) Crystallins are separated into two classes: taxon-specific, or enzyme, and ubiquitous. The latter class constitutes the major proteins of vertebrate eye lens and maintains the transparency and refractive index of the lens. Since lens central fiber cells lose their nuclei during development, these crystallins are made and then retained throughout life, making them extremely stable proteins. Mammalian lens crystallins are divided into alpha, beta, and gamma families; beta and gamma crystallins are also considered as a superfamily. Alpha and beta families are further divided into acidic and basic groups. Seven protein regions exist in crystallins: four homologous motifs, a connecting peptide, and N- and C-terminal extensions. Gamma-crystallins are a homogeneous group of highly symmetrical, monomeric proteins typically lacking connecting peptides and terminal extensions. They are differentially regulated after early development. Four gamma-crystallin genes (gamma-A through gamma-D) and three pseudogenes (gamma-E, gamma-F, gamma-G) are tandemly organized in a genomic segment as a gene cluster. Whether due to aging or mutations in specific genes, gamma-crystallins have been involved in cataract formation. [provided by RefSeq, Jul 2008] 
CRYGD Gene-Disease associations (from GenCC):
- cataract 4 multiple typesInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
- cataract - microcornea syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- cerulean cataractInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- coralliform cataractInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- early-onset lamellar cataractInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- early-onset nuclear cataractInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- pulverulent cataractInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87). 
BP6
Variant 2-208124445-G-A is Benign according to our data. Variant chr2-208124445-G-A is described in ClinVar as Benign. ClinVar VariationId is 260063.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0111 (1698/152306) while in subpopulation NFE AF = 0.0173 (1176/68012). AF 95% confidence interval is 0.0165. There are 9 homozygotes in GnomAd4. There are 780 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check. 
BS2
High AC in GnomAd4 at 1698 AD gene. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| CRYGD | NM_006891.4 | c.9+20C>T | intron_variant | Intron 1 of 2 | ENST00000264376.5 | NP_008822.2 | ||
| LOC100507443 | NR_038437.1 | n.97+5220G>A | intron_variant | Intron 1 of 2 | 
Ensembl
Frequencies
GnomAD3 genomes  0.0112  AC: 1697AN: 152188Hom.:  9  Cov.: 33 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
1697
AN: 
152188
Hom.: 
Cov.: 
33
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.0116  AC: 2206AN: 190104 AF XY:  0.0119   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
2206
AN: 
190104
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.0148  AC: 21183AN: 1430530Hom.:  195  Cov.: 35 AF XY:  0.0144  AC XY: 10214AN XY: 708586 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
21183
AN: 
1430530
Hom.: 
Cov.: 
35
 AF XY: 
AC XY: 
10214
AN XY: 
708586
show subpopulations 
African (AFR) 
 AF: 
AC: 
75
AN: 
33148
American (AMR) 
 AF: 
AC: 
345
AN: 
38720
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
606
AN: 
25404
East Asian (EAS) 
 AF: 
AC: 
2
AN: 
38496
South Asian (SAS) 
 AF: 
AC: 
272
AN: 
82160
European-Finnish (FIN) 
 AF: 
AC: 
367
AN: 
50218
Middle Eastern (MID) 
 AF: 
AC: 
119
AN: 
5638
European-Non Finnish (NFE) 
 AF: 
AC: 
18551
AN: 
1097448
Other (OTH) 
 AF: 
AC: 
846
AN: 
59298
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.488 
Heterozygous variant carriers
 0 
 1418 
 2836 
 4253 
 5671 
 7089 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 672 
 1344 
 2016 
 2688 
 3360 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.0111  AC: 1698AN: 152306Hom.:  9  Cov.: 33 AF XY:  0.0105  AC XY: 780AN XY: 74486 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
1698
AN: 
152306
Hom.: 
Cov.: 
33
 AF XY: 
AC XY: 
780
AN XY: 
74486
show subpopulations 
African (AFR) 
 AF: 
AC: 
123
AN: 
41564
American (AMR) 
 AF: 
AC: 
159
AN: 
15304
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
69
AN: 
3470
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5180
South Asian (SAS) 
 AF: 
AC: 
11
AN: 
4832
European-Finnish (FIN) 
 AF: 
AC: 
48
AN: 
10624
Middle Eastern (MID) 
 AF: 
AC: 
13
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
1176
AN: 
68012
Other (OTH) 
 AF: 
AC: 
29
AN: 
2116
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.495 
Heterozygous variant carriers
 0 
 93 
 186 
 279 
 372 
 465 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 20 
 40 
 60 
 80 
 100 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
ClinVar
Significance: Benign 
Submissions summary: Benign:3 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not specified    Benign:1 
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided    Benign:1 
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Aculeiform cataract    Benign:1 
Jan 13, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.